|
|
protein lipid complex subunit organization
|
GO:0071825 |
12 |
1.000
|
Human Mouse |
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
6 |
1.000
|
Human Mouse |
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
1.000
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.999
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.997
|
Human Mouse |
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.997
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.991
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.986
|
Mouse |
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.984
|
Human Mouse |
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.982
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.979
|
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.976
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.973
|
Mouse |
|
|
low density lipoprotein particle remodeling
|
GO:0034374 |
2 |
0.967
|
Mouse |
|
|
lipoprotein catabolic process
|
GO:0042159 |
7 |
0.960
|
Mouse |
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.945
|
Human Mouse |
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.943
|
|
|
|
protein lipid complex remodeling
|
GO:0034368 |
6 |
0.943
|
Human Mouse |
|
|
plasma lipoprotein particle clearance
|
GO:0034381 |
13 |
0.921
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.916
|
Mouse |
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.908
|
Human Mouse |
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.898
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.897
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.894
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.890
|
|
|
|
glycerolipid catabolic process
|
GO:0046503 |
16 |
0.872
|
|
|
|
plasma lipoprotein particle organization
|
GO:0071827 |
11 |
0.866
|
Human Mouse |
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.860
|
Human Mouse |
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.846
|
Mouse |
|
|
positive regulation of macrophage derived foam cell differentiation
|
GO:0010744 |
4 |
0.842
|
|
|
|
triglyceride rich lipoprotein particle remodeling
|
GO:0034370 |
2 |
0.841
|
Human Mouse |
|
|
triglyceride catabolic process
|
GO:0019433 |
9 |
0.835
|
|
|
|
lipoprotein biosynthetic process
|
GO:0042158 |
33 |
0.804
|
|
|
|
acylglycerol homeostasis
|
GO:0055090 |
16 |
0.784
|
Human Mouse |
|
|
negative regulation of fibrinolysis
|
GO:0051918 |
1 |
0.776
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.771
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.770
|
|
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.768
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.758
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.754
|
|
|
|
regulation of cholesterol transport
|
GO:0032374 |
17 |
0.739
|
|
|
|
intestinal cholesterol absorption
|
GO:0030299 |
5 |
0.724
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.721
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.717
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.701
|
|
|
|
regulation of cholesterol biosynthetic process
|
GO:0045540 |
8 |
0.693
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.688
|
Mouse |
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.686
|
|
|
|
sterol biosynthetic process
|
GO:0016126 |
17 |
0.676
|
|
|
|
positive regulation of cholesterol storage
|
GO:0010886 |
3 |
0.649
|
|
|
|
negative regulation of hemostasis
|
GO:1900047 |
11 |
0.647
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.638
|
|
|
|
negative regulation of coagulation
|
GO:0050819 |
11 |
0.630
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.618
|
Human Mouse |
|
|
hemostasis
|
GO:0007599 |
78 |
0.611
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.608
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.601
|
Human Mouse |
|
|
lipid localization
|
GO:0010876 |
126 |
0.595
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.570
|
|
|
|
regulation of cholesterol esterification
|
GO:0010872 |
2 |
0.565
|
Human Mouse |
|
|
reverse cholesterol transport
|
GO:0043691 |
6 |
0.563
|
Human |
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.558
|
|
|
|
acylglycerol catabolic process
|
GO:0046464 |
11 |
0.557
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.535
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.535
|
Human Mouse |
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.529
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.521
|
|
|
|
sterol esterification
|
GO:0034434 |
3 |
0.520
|
Human Mouse |
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.511
|
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.508
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.503
|
Human |
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.500
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.497
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.496
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.490
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.482
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.478
|
Mouse |
|
|
plasma lipoprotein particle assembly
|
GO:0034377 |
6 |
0.478
|
Human |
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.472
|
Human |
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.469
|
Mouse |
|
|
coagulation
|
GO:0050817 |
78 |
0.468
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.448
|
|
|
|
cholesterol biosynthetic process
|
GO:0006695 |
15 |
0.440
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.432
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.428
|
|
|
|
cholesterol catabolic process
|
GO:0006707 |
5 |
0.428
|
Mouse |
|
|
glucocorticoid metabolic process
|
GO:0008211 |
9 |
0.424
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.420
|
|
|
|
triglyceride mobilization
|
GO:0006642 |
5 |
0.410
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.403
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.401
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.399
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.397
|
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.389
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.377
|
|
|
|
negative regulation of serine type endopeptidase activity
|
GO:1900004 |
2 |
0.374
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.372
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.367
|
|
|
|
high density lipoprotein particle assembly
|
GO:0034380 |
3 |
0.354
|
Human |
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.354
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.351
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.347
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.345
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.344
|
|
|
|
lipid digestion
|
GO:0044241 |
7 |
0.333
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.330
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.323
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.321
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
17 |
0.319
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.315
|
|
|
|
negative regulation of blood coagulation
|
GO:0030195 |
11 |
0.308
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.305
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.304
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.301
|
|
|
|
positive regulation of lipid storage
|
GO:0010884 |
10 |
0.299
|
|
|
|
positive regulation of protein kinase c activity
|
GO:1900020 |
1 |
0.297
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.296
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.292
|
|
|
|
regulation of serine type endopeptidase activity
|
GO:1900003 |
2 |
0.289
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.288
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.287
|
Mouse |
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.286
|
|
|
|
positive regulation of cholesterol esterification
|
GO:0010873 |
1 |
0.284
|
Human Mouse |
|
|
neutral lipid catabolic process
|
GO:0046461 |
11 |
0.281
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.279
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.279
|
Human Mouse |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.275
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.274
|
Human Mouse |
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.274
|
|
|
|
positive regulation of coagulation
|
GO:0050820 |
13 |
0.272
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.271
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.270
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.267
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.259
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.259
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.258
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.254
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.253
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.248
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.247
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.240
|
Mouse |
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.240
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.238
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.236
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.231
|
|
|
|
astrocyte activation
|
GO:0048143 |
2 |
0.229
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.223
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.221
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.218
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.217
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.216
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.215
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.213
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.213
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.211
|
Human Mouse |
|
|
very low density lipoprotein particle remodeling
|
GO:0034372 |
1 |
0.210
|
Human Mouse |
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.210
|
Human Mouse |
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.209
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.208
|
Human Mouse |
|
|
macromolecular complex remodeling
|
GO:0034367 |
6 |
0.206
|
Human Mouse |
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.205
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.203
|
|
|
|
steroid esterification
|
GO:0034433 |
3 |
0.200
|
Human Mouse |
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.198
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.198
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.197
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.195
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.192
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.188
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.182
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.181
|
|
|
|
hepatocyte growth factor receptor signaling pathway
|
GO:0048012 |
3 |
0.180
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.179
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.179
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.178
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.178
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.177
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.177
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.176
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.173
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.172
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.171
|
Human Mouse |
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.168
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.168
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.168
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.164
|
|
|
|
phospholipid homeostasis
|
GO:0055091 |
6 |
0.163
|
Human |
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.163
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.160
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.160
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.156
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.155
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.151
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.151
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.150
|
|
|
|
low density lipoprotein particle clearance
|
GO:0034383 |
8 |
0.148
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.148
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.148
|
Human |
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.145
|
Human Mouse |
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.144
|
Human Mouse |
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.143
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.142
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.142
|
|
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
12 |
0.140
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.140
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.138
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.138
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.136
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.136
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.135
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.135
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.134
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.133
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.131
|
|
|
|
regulation of digestive system process
|
GO:0044058 |
13 |
0.130
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.130
|
Human Mouse |
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.130
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.129
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.128
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.128
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.128
|
Mouse |
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.127
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.127
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.126
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.125
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.124
|
|
|
|
trophoblast giant cell differentiation
|
GO:0060707 |
15 |
0.123
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.121
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.121
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.121
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.121
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.120
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.120
|
|
|
|
organophosphate ester transport
|
GO:0015748 |
28 |
0.119
|
Human |
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.118
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.118
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.117
|
|
|
|
regulation of nitrogen cycle metabolic process
|
GO:1903314 |
1 |
0.116
|
|
|
|
branching involved in salivary gland morphogenesis
|
GO:0060445 |
26 |
0.116
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.115
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.115
|
Human |
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.114
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.114
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.114
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.113
|
|
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
8 |
0.112
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.111
|
Mouse |
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.111
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.111
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.111
|
Human |
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.111
|
Mouse |
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.110
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.109
|
Mouse |
|
|
response to insulin
|
GO:0032868 |
100 |
0.108
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.106
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.106
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.105
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.104
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.103
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.103
|
|
|
|
triglyceride homeostasis
|
GO:0070328 |
15 |
0.103
|
Human |
|
|
ammonia assimilation cycle
|
GO:0019676 |
2 |
0.102
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.101
|
Human |
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.100
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.100
|
|
|
|
negative regulation of wound healing
|
GO:0061045 |
14 |
0.099
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.099
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.097
|
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.096
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.095
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.095
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.095
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.095
|
Mouse |
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.094
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.094
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.094
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.093
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.093
|
|
|
|
phospholipid transport
|
GO:0015914 |
21 |
0.093
|
Human |
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.092
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.091
|
Human |
|
|
amide transport
|
GO:0042886 |
138 |
0.091
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.091
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.090
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.090
|
|
|
|
regulation of ammonia assimilation cycle
|
GO:2001248 |
1 |
0.090
|
|
|
|
sterol catabolic process
|
GO:0016127 |
5 |
0.089
|
Mouse |
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.088
|
Human |
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.088
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.088
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.087
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.086
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.086
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.086
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.085
|
|
|
|
response to bile acid
|
GO:1903412 |
1 |
0.085
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.085
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.084
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.084
|
Human |
|
|
angiogenesis
|
GO:0001525 |
201 |
0.084
|
|
|
|
regulation of lipoprotein metabolic process
|
GO:0050746 |
4 |
0.083
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.083
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.083
|
Human |
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.083
|
|
|
|
positive regulation of lipid biosynthetic process
|
GO:0046889 |
18 |
0.082
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.082
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.082
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.080
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.080
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.078
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.078
|
|
|
|
positive regulation of cholesterol homeostasis
|
GO:2000189 |
2 |
0.077
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.076
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.076
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.076
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.075
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.075
|
Human |
|
|
connective tissue development
|
GO:0061448 |
179 |
0.075
|
|
|
|
regulation of glutamate metabolic process
|
GO:2000211 |
1 |
0.074
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.074
|
|
|
|
phasic smooth muscle contraction
|
GO:0014821 |
8 |
0.074
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.074
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.074
|
|
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.073
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.073
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.073
|
Human |
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.073
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.073
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.072
|
Mouse |
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.072
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.072
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.072
|
|
|
|
fatty acid transmembrane transport
|
GO:1902001 |
1 |
0.071
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.071
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.071
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.071
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.071
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.070
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.070
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.070
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.070
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.069
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.069
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.069
|
Mouse |
|
|
macrophage derived foam cell differentiation
|
GO:0010742 |
6 |
0.069
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.069
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.069
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.069
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.068
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.068
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.068
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.068
|
Human |
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.068
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.068
|
|
|
|
9 cis retinoic acid biosynthetic process
|
GO:0042904 |
5 |
0.067
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.067
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.067
|
Mouse |
|
|
fatty acid catabolic process
|
GO:0009062 |
25 |
0.067
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.067
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.066
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.066
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.065
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.065
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.065
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.065
|
Mouse |
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.064
|
|
|
|
high density lipoprotein particle remodeling
|
GO:0034375 |
4 |
0.064
|
|
|
|
regulation of alcohol biosynthetic process
|
GO:1902930 |
16 |
0.064
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.063
|
Mouse |
|
|
protein secretion
|
GO:0009306 |
111 |
0.063
|
Human |
|
|
cell maturation
|
GO:0048469 |
127 |
0.063
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.062
|
Human |
|
|
organ or tissue specific immune response
|
GO:0002251 |
13 |
0.062
|
Mouse |
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.062
|
|
|
|
regulation of protein kinase c activity
|
GO:1900019 |
1 |
0.062
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.062
|
|
|
|
9 cis retinoic acid metabolic process
|
GO:0042905 |
5 |
0.062
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.061
|
Human |
|
|
regulation of cholesterol storage
|
GO:0010885 |
4 |
0.061
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.061
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.061
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.060
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.060
|
|
|
|
regulation of urea metabolic process
|
GO:0034255 |
1 |
0.060
|
|
|
|
regulation of antimicrobial peptide biosynthetic process
|
GO:0002805 |
1 |
0.060
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.060
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.059
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.058
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.058
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.058
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.058
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.058
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.057
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.057
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.056
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.056
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.055
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.055
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.055
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.055
|
|
|
|
excretion
|
GO:0007588 |
22 |
0.055
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.054
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.054
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.054
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.053
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.053
|
|
|
|
regulation of lipid storage
|
GO:0010883 |
20 |
0.053
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.053
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.053
|
Human |
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.053
|
|
|
|
adiponectin activated signaling pathway
|
GO:0033211 |
4 |
0.053
|
|
|
|
very long chain fatty acid catabolic process
|
GO:0042760 |
2 |
0.053
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.053
|
|
|
|
smad protein signal transduction
|
GO:0060395 |
21 |
0.052
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.052
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.052
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.052
|
Human |
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.052
|
|
|
|
regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902041 |
22 |
0.051
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.051
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.051
|
|
|
|
astrocyte development
|
GO:0014002 |
12 |
0.051
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.051
|
|
|
|
ovarian follicle rupture
|
GO:0001543 |
2 |
0.051
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.050
|
Human |
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.050
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.050
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.050
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.050
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.050
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.048
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.048
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.048
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.048
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.048
|
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.047
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.047
|
Human |
|
|
nitric oxide mediated signal transduction
|
GO:0007263 |
4 |
0.047
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.047
|
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.047
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.047
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.046
|
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.046
|
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
28 |
0.046
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.045
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.045
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.045
|
Mouse |
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.045
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.045
|
|
|
|
regulation of phospholipid transport
|
GO:2001138 |
4 |
0.045
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.045
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.045
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.045
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.044
|
|
|
|
regulation of vitamin d biosynthetic process
|
GO:0060556 |
1 |
0.044
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.044
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.044
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.043
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.043
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.043
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.043
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.043
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.043
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.043
|
Human |
|
|
peristalsis
|
GO:0030432 |
8 |
0.043
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.043
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.042
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.042
|
Human |
|
|
positive regulation of cellular carbohydrate metabolic process
|
GO:0010676 |
29 |
0.042
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.042
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.042
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.042
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.041
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.041
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.041
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.041
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.041
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.041
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.041
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.041
|
|
|
|
regulation of glutamine family amino acid metabolic process
|
GO:0000820 |
1 |
0.041
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.041
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.041
|
|
|
|
response to chromate
|
GO:0046687 |
1 |
0.040
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.040
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.040
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.040
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.040
|
|
